
Home » BIOBALANCE AWARDED PATENT FOR PROBACTRIX
BIOBALANCE AWARDED PATENT FOR PROBACTRIX
May 3, 2006
BioBalance has received a U.S. patent for its inflammatory bowel disease treatment Probactrix, the company said.
BioBalance received the patent March 28 for Probactrix, a strain of E.coli. Inflammatory bowel disease includes Crohn's disease and ulcerative colitis, which together affect 1 million Americans, BioBalance said.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr